Cargando…
Single-cell RNA sequencing reveals that BMPR2 mutation regulates right ventricular function via ID genes
BACKGROUND: Mutations in bone morphogenetic protein type II receptor (BMPR2) have been found in patients with congenital heart disease-associated pulmonary arterial hypertension (CHD-PAH). Our study aimed to clarify whether deficient BMPR2 signalling acts through downstream effectors, inhibitors of...
Autores principales: | Du, Mingxia, Jiang, Haibin, Liu, Hongxian, Zhao, Xin, Zhou, Yu, Zhou, Fang, Piao, Chunmei, Xu, Guoqiang, Ma, Feng, Wang, Jianan, Perros, Frederic, Morrell, Nicholas W., Gu, Hong, Yang, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260124/ https://www.ncbi.nlm.nih.gov/pubmed/34857612 http://dx.doi.org/10.1183/13993003.00327-2021 |
Ejemplares similares
-
The lysosomal inhibitor, chloroquine, increases cell surface BMPR-II levels and restores BMP9 signalling in endothelial cells harbouring BMPR-II mutations
por: Dunmore, Benjamin J., et al.
Publicado: (2013) -
Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2
por: Novoyatleva, Tatyana, et al.
Publicado: (2021) -
Author Correction: Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2
por: Novoyatleva, Tatyana, et al.
Publicado: (2022) -
Targeting translational read-through of premature termination
mutations in BMPR2 with PTC124 for pulmonary arterial
hypertension
por: Long, Lu, et al.
Publicado: (2020) -
Different Cytokine Patterns in BMPR2-Mutation-Positive Patients and Patients With Pulmonary Arterial Hypertension Without Mutations and Their Influence on Survival
por: Schwiening, Max, et al.
Publicado: (2022)